GPR43 Antibodies

Santa Cruz Biotechnology provides a broad selection of GPR43 monoclonal antibodies for advanced research in immunology and cell signaling. GPR43 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GPR43, also known as Free Fatty Acid Receptor 2 (FFAR2), plays a crucial role in mediating the effects of short-chain fatty acids on immune responses and metabolic processes. The receptor significantly influences inflammation regulation and has been implicated in various metabolic disorders, making GPR43 a key target for therapeutic interventions. Understanding GPR43 function is essential for advancing research in metabolic health and immune regulation. Researchers worldwide rely on GPR43 monoclonal antibodies to investigate receptor expression patterns in different tissues and cell types. The specificity and reliability of GPR43 monoclonal antibodies enable precise detection and characterization of receptor activity across multiple experimental applications. Santa Cruz Biotechnology monoclonal antibodies support researchers in making meaningful discoveries about GPR43's role in human health and disease.